Publicaciones en las que colabora con Ángel Concheiro Nine (17)

2019

  1. ScCO2-foamed silk fibroin aerogel/poly(ϵ-caprolactone) scaffolds containing dexamethasone for bone regeneration

    Journal of CO2 Utilization, Vol. 31, pp. 51-64

2018

  1. Mobility of Water and Polymer Species and Rheological Properties of Supramolecular Polypseudorotaxane Gels Suitable for Bone Regeneration

    Bioconjugate Chemistry, Vol. 29, Núm. 2, pp. 503-516

2017

  1. Biodegradable PCL/fibroin/hydroxyapatite porous scaffolds prepared by supercritical foaming for bone regeneration

    International Journal of Pharmaceutics, Vol. 527, Núm. 1-2, pp. 115-125

  2. Structure-Performance Relationships of Temperature-Responsive PLGA-PEG-PLGA Gels for Sustained Release of Bone Morphogenetic Protein-2

    Journal of Pharmaceutical Sciences, Vol. 106, Núm. 11, pp. 3353-3362

2015

  1. Bone critical defect repair with poloxamine-cyclodextrin supramolecular gels

    International Journal of Pharmaceutics, Vol. 495, Núm. 1, pp. 463-473

2014

  1. Bone regeneration induced by an in situ gel-forming poloxamine, bone morphogenetic protein-2 system

    Journal of Biomedical Nanotechnology, Vol. 10, Núm. 6, pp. 959-969

2013

  1. Poly-(cyclo)dextrins as ethoxzolamide carriers in ophthalmic solutions and in contact lenses

    Carbohydrate Polymers, Vol. 98, Núm. 2, pp. 1343-1352

  2. Tratado general de biofarmacia y farmacocinética: Volumen I: LADME. Análisis farmacocinético. Biodisponibilidad y bioequivalencia

    Síntesis

2009

  1. hGH release from directly compressed hGH-PLGA biodegradable implantable tablets: Influence of physicomechanical factors

    European Polymer Journal, Vol. 45, Núm. 10, pp. 2830-2838

2005

  1. Structural properties of biodegradable polyesters and rheological behaviour of their dispersions and films

    Journal of Biomaterials Science, Polymer Edition, Vol. 16, Núm. 5, pp. 629-641

2004

  1. Rheological properties of PLGA film-based implants: Correlation with polymer degradation and SPf66 antimalaric synthetic peptide release

    Biomaterials, Vol. 25, Núm. 5, pp. 925-931

1987

  1. Dissolution rate and bioavailability of spironolactone tablets: Effect of various technological factors

    Drug Development and Industrial Pharmacy, Vol. 13, Núm. 12, pp. 2301-2314

1986

  1. EFECTO DEL pH Y FLUJO URINARIO SOBRE LA EVALUACION DE LA BIODISPONIBILIDAD ORAL DE LA SULFADIAZINA

    Ciencia e Industria Farmaceutica, Vol. 5, Núm. 10, pp. 309-315

  2. Limitations of the MANOVA of statistical moments in bioequivalence trials of drugs with slow elimination rate: A study with spironolactone

    Biopharmaceutics & Drug Disposition, Vol. 7, Núm. 3, pp. 253-264

1984

  1. APPLICATION DU MANOVA DES MOMENTS STATISTIQUES DANS UNE ETUDE DE LA BIODISPONIBILITE DE TROIS FORMULATIONS DE PARACETAMOL

    Pharmaceutica Acta Helvetiae, Vol. 59, Núm. 4, pp. 109-111

1982

  1. BIODISPONIBILIDAD ORAL DE CEFADROXIL: INFLUENCIA DE LOS ALIMENTOS

    Archivos de Farmacologia y Toxicologia, Vol. 8, Núm. 3, pp. 171-178

  2. METODO DENSITOMETRICO PARA LA DETERMINACION DE PARACETAMOL EN LA ORINA

    Ciencia e Industria Farmaceutica, Vol. 1, Núm. 2, pp. 38-41